HAE
Haemonetics
$101.06
−$2.10 (−2.04%)Sep 10, 2026
Key metrics
The numbers that frame HAE today
- Market cap
- $4.60B
- P/E (TTM)
- 47.8
- EV / FCF
- 22.5
- Gross margin
- 59%
- EV / Sales
- 4.1
- ROIC
- 8.5%
- Div yield
- 0%
- Debt / equity
- 1.4
- 52wk Low
- $47.32
- 52wk High
- $109.57
Growth
Revenue and earnings trend for HAE
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about HAE
Is Haemonetics a good buy?
Yes. Haemonetics has excellent quality and excellent momentum. Both signals support the setup. Growth looks strong, which supports the long-term business case. We think Haemonetics is selling at a fair price.
What is the market capitalization of HAE?
Haemonetics's market capitalization is $4.60B.
What is the P/E ratio for HAE stock?
Haemonetics's current P/E ratio is 47.8.
What is the 52-week high for HAE stock?
The 52-week high for Haemonetics is $109.57. The current close of $101.06 is 7.8% below that high.
What is the 52-week low for HAE stock?
The 52-week low for Haemonetics is $47.32. The current close of $101.06 is 113.6% above that low.
Does HAE stock pay dividends?
Haemonetics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for HAE?
Haemonetics's Debt / Equity ratio is 1.4.